|
此文章由 moris 原创或转贴,不代表本站立场和观点,版权归 oursteps.com.au 和作者 moris 所有!转贴必须注明作者、出处和本声明,并保持内容完整
Scientific publishing
The value of current independent studies is considered by some[who?][quantify] to be problematic because, due to restrictive end-user agreements, independent researchers sometimes cannot obtain GM plants for study. Cornell University's Elson Shields, the spokesperson for a group of scientists who oppose this practice, submitted a statement to the United States Environmental Protection Agency protesting that "as a result of restrictive access, no truly independent research can be legally conducted on many critical questions regarding the technology".[42] Scientific American noted that several studies that were initially approved by seed companies were later blocked from publication when they returned "unflattering" results. While recognising that seed companies' intellectual property rights need to be protected, Scientific American calls the practice dangerous and has called for the restrictions on research in the end-user agreements to be lifted immediately and for the EPA to require, as a condition of approval, that independent researchers have unfettered access to GM products for testing.[43] In February 2009, the American Seed Trade Association agreed that they "would allow researchers greater freedom to study the effects of GM food crops." This agreement left many scientists optimistic about the future, but there is little optimism as to whether this agreement has the ability to "alter what has been a research environment rife with obstruction and suspicion."[42][44]
独立科学家要研究下转基因还要受用户协议限制,转基因公司还可以不让他们公开发表论文。可以想见有多少出自美国的结论是独立可信的。转基因公司科学家出的报告谁爱信谁信 |
|